Literature DB >> 6153937

Lung damage from cytotoxic drugs.

C H Collis.   

Abstract

Bleomycin, busulphan, and methotrexate are by far the commonest cytotoxic drugs to cause interstitial pneumonitis. However, many other cytotoxic drugs have been reported to produce similar lung damage. Combined effects of these drugs, and of the drugs with other agents that cause lung damage, such as oxygen and radiation, may result in enhancement of lung damage. Early diagnosis, made possible by awareness of this complication and its correct investigation, may reduce severe morbidity and mortality. In some instances, factors that predispose to lung damage are known, and these have been studied in experimental animals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153937     DOI: 10.1007/BF00255453

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  113 in total

1.  Multiple pulmonary lesions in a patient treated with BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) for glioblastoma multiforme.

Authors:  P A Bellot; R O Valdiserri
Journal:  Cancer       Date:  1979-01       Impact factor: 6.860

2.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

3.  Lung disease associated with methotrexate therapy.

Authors:  K S Bhat; K R Anderson; R D Stewart
Journal:  Aust N Z J Med       Date:  1974-06

4.  Syndrome resembling Addison's disease following prolonged treatment with busulphan.

Authors:  B P Harrold
Journal:  Br Med J       Date:  1966-02-19

5.  [Diffuse interstitial fibrosis of the lung in Hodgkin's disease treated by high doses of endoxan].

Authors:  R André; H Rochant; B Dreyfus; G Duhamel; J C Péchère
Journal:  Bull Mem Soc Med Hop Paris       Date:  1967 Nov 3-10

6.  Sclerosing alveolitis induced by cyclophosphamide. Ultrastructural observations on alveolar injury and repair.

Authors:  V E Gould; J Miller
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

7.  Cyclophosphamide pneumonitis.

Authors:  G J Mark; A Lehimgar-Zadeh; B D Ragsdale
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

8.  Pulmonary toxicity of bischloronitrosourea: report of a case with transient response to corticosteroid therapy.

Authors:  J E Richter; R Hastedt; J F Dalton; D Marshall; L W Raymond
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

9.  Experimentally induced bleomycin sulfate pulmonary toxicity: histopathologic and ultrastructural study in the pheasant.

Authors:  C W Bedrossian; S D Greenberg; D H Yawn; R M O'Neal
Journal:  Arch Pathol Lab Med       Date:  1977-05       Impact factor: 5.534

10.  Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.

Authors:  P S Schein; V T DeVita; S Hubbard; B A Chabner; G P Canellos; C Berard; R C Young
Journal:  Ann Intern Med       Date:  1976-10       Impact factor: 25.391

View more
  18 in total

Review 1.  Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy.

Authors:  Galen Leung; Marianna Papademetriou; Shannon Chang; Francis Arena; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

2.  Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.

Authors:  Martha W den Hollander; Nico-Derk L Westerink; Sjoukje Lubberts; Alfons H H Bongaerts; Rienhart F E Wolf; Renska Altena; Janine Nuver; Sjoukje F Oosting; Elisabeth G E de Vries; Anna M E Walenkamp; Coby Meijer; Jourik A Gietema
Journal:  Oncologist       Date:  2016-06-21

3.  Lung damage in the rat after irradiation and treatment with cytotoxic drugs.

Authors:  A E Varekamp; A J de Vries; A Hagenbeek
Journal:  Br J Cancer Suppl       Date:  1986

4.  Experimental bleomycin lung in mice. A contribution to the pathogenesis of pulmonary fibrosis.

Authors:  E Fasske; K Morgenroth
Journal:  Lung       Date:  1983       Impact factor: 2.584

5.  Effects of hydroxyurea and benzo(a)pyrene on DNA synthesis in the isolated perfused rat lung.

Authors:  T Imamura; W F Busby; M E Goldman; G N Wogan; H Brunengraber
Journal:  Bull Environ Contam Toxicol       Date:  1982-02       Impact factor: 2.151

6.  Interstitial pneumonitis secondary to azathioprine in a renal transplant patient.

Authors:  D J Carmichael; D V Hamilton; D B Evans; P G Stovin; R Y Calne
Journal:  Thorax       Date:  1983-12       Impact factor: 9.139

7.  Treatment of small cell lung carcinoma in association with cryptogenic fibrosing alveolitis.

Authors:  J R Lipton; J Winstanley; K Carroll; J J Mould; N Thatcher
Journal:  Postgrad Med J       Date:  1982-03       Impact factor: 2.401

8.  Lung function changes after allogenic bone marrow transplantation.

Authors:  H Link; U Reinhard; M Blaurock; P Ostendorf
Journal:  Thorax       Date:  1986-07       Impact factor: 9.139

9.  Pulmonary disease following allogeneic bone marrow transplantation.

Authors:  M Murray; D S O'Briain; J Prichard; S R McCann
Journal:  Ir J Med Sci       Date:  1989-02       Impact factor: 1.568

Review 10.  Long-term complications of chemotherapy for germ cell tumours.

Authors:  Uzair B Chaudhary; Jason R Haldas
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.